About Passage Bio (PASG)
Passage Bio Inc is a preclinical stage genetic medicines company. The Company is focused on developing transformative therapies for rare, monogenic central nervous system (CNS). The Company is developing a portfolio of six life transforming AAV-deliv... Read more
- USD0.32
- USD0.33
- USD0.32
- USD1.64
- -23.90%
- --
- 88.37k
- 182.33k
- 21M
- 0.30
- -75.50%
Stock News
last year
Why Tuesday's pullback is a healthy break in the rally and how we are playing it
CNBC
last year
ESPN Bet plans launch in New York, the largest U.S. betting market
CNBC
last year
Moving to New York City? Be ready to drop more than $10,000 up front to rent an apartment.
MarketWatch
last year
Tesla leads 11% annual drop in EV prices as demand slowdown continues
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
